Eskata

Eskata is a prescription medication used to treat seborrheic keratosis which is a condition of non-cancerous tan, brown, or black skin growths. 

Eskata belongs to a group of drugs called antiseptics. It is unknown how Eskata works to treat seborrheic keratosis.

This medication comes in topical form to be applied by a healthcare professional.

Common side effects of Eskata include redness, stinging, and swelling of the skin.

Eskata is a prescription medication used to treat seborrheic keratosis which is a condition of non-cancerous tan, brown, or black skin growths. Eskata is only for raised seborrheic keratosis.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Serious side effects have been reported with Eskata. See the “Eskata Precautions” section.

Common side effects of Eskata include the following skin reactions:

• redness
• stinging
• swelling
• scaling 
• crusting
• itching

This is not a complete list of Eskata side effects. Ask your doctor or pharmacist for more information.

Tell your doctor if you have any side effects that bother you or that do not go away.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

No drug interactions have been determined by the manufacturer. However, you should tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Not all drug interactions are known or reported and new drug interactions are continually being reported.

Serious side effects have been reported with Eskata including the following:

• severe skin reactions. Tell your healthcare provider if you have any sores or scarring after receiving Eskata.
• eye problems when eye is exposed to eye(s). Wash hands after applying Eskata. If accidental exposure of eye(s) to Eskata, flush eye(s) with water for 15-30 minutes and monitor.

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Eskata, there are no specific foods that you must exclude from your diet when receiving this medication.

Before taking Eskata, tell your doctor about all of your medical conditions. Especially tell your doctor if you:

• are allergic to Eskata or to any of its ingredients
• have or have had treatments for seborrheic keratosis
• have other skin problems
• are pregnant or plan to become pregnant
• are breastfeeding or plan to breastfeed

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Tell your doctor if you are pregnant or plan to become pregnant.

Eskata is not absorbed into the system after using topically. Eskata use during pregnancy is not expected to result in Eskata exposure to an unborn baby.

Tell your doctor if you are breastfeeding or plan to breastfeed.

Eskata is not absorbed into the system after using topically. Eskata while breastfeeding is not expected to result in Eskata exposure to a baby.

Eskata is available in a topical form to be applied by a healthcare professional. It is applied 4 times, approximately 1 minute apart, to the targeted lesion(s) during a single in-office treatment session. 

Eskata should not be applied to open or infected seborrheic keratosis.

Eskata should only be used topically.

A healthcare professional will apply Eskata to seborrheic keratosis growths 4 times about 1 minute apart during one office visit.

Eskata treatment may be repeated in 3 weeks if seborrheic keratosis is not cleared.

If Eskata is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.